Main Menu
Main Menu
Stay updated with news and stories of strength and hope. Learn how biomarker testing is unlocking personalized treatment options and how clinical trials are offering new paths forward.
Q&A About Informed Decision-Making with Caroline Crooms, MD, MPH When you’re facing a brain tumor diagnosis, it’s easy to feel like things are happening to you, but informed decision-making helps put you back in the driver’s seat. To help patients and caregivers navigate the complex choices that come with a diagnosis, Jenna Tozzi, RN, Senior Director of Community at the National Brain Tumor Society, […] March 17, 2026
Biomarker Testing Provides Clarity About Amanda’s Meningioma Diagnosis Less than a year after being diagnosed with meningioma, Amanda D. found herself walking along the Asbury Park Boardwalk with her husband, three daughters, and a close friend. As they took part in the National Brain Tumor Society’s New Jersey Brain Tumor Walk, they paused to watch dolphins playing in the ocean. This unexpected moment […] February 17, 2026
Brain Tumor Board 101: Answers to Frequently Asked Questions When a brain tumor diagnosis is complex or unclear, providers often bring it to a tumor board, a multidisciplinary meeting where experts come together to review a patient’s case and recommend the best next steps. “The treatment of brain tumors is complicated,” said John de Groot, MD, Neuro-oncology Division Chief at the University of California, […] February 12, 2026
Why a Couple Turned to Clinical Trials After a Brain Tumor Recurrence On May 2, 2020, a quiet night at home turned into a life-altering moment when Anthony experienced a seizure that led to a brain tumor diagnosis during the height of the COVID-19 pandemic. Anthony and his wife, Alexandra, share their journey through surgery, radiation, chemotherapy, recurrence, and the decision to pursue clinical trials. Their story […] January 6, 2026
Biomarker Testing Gave the Peterson Family More Time When Darlene Peterson was diagnosed with a brain tumor, doctors first believed it was a low-grade glioma. Initial tests pointed in that direction, but biomarker testing revealed the truth: her tumor was actually a grade 4 glioblastoma. In this video, the Peterson family shares how accurately identifying her brain tumor through biomarker testing changed everything. […] October 2, 2025
Have you undergone biomarker testing for your brain tumor or enrolled in a clinical trial? NBTS wants to hear from you!